News

Filter

Otsuka said to be buying Astex Pharma

05-09-2013

Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

EU approval for Janssen-Cilag's Dacogen and Novartis/Vectura's Seebri Breezhealer

01-10-2012

The European Commission on Friday approved the marketing authorization for Janssen-Cilag's (a unit of…

Astex PharmaceuticalsDacogenEuropeJanssen-CilagJohnson & JohnsonNovartisOncologyPharmaceuticalRegulationRespiratory and PulmonarySeebri BreezhalerVectura

Astex Pharma shares down after company drops amuvatinib development

25-09-2012

US drug developer Astex Pharmaceuticals (Nasdaq: ASTX) saw its shares fall 8.1% to $3.05 by close last…

amuvatinibAstex PharmaceuticalsBiotechnologyLicensingOncologyPharmaceuticalResearch

US FDA delays Eisai's Dacogen for AML; accepts perampanel NDA

08-03-2012

The US Food and Drug Administration has issued a Complete Response Letter to Japanese drug major Eisai…

Astex PharmaceuticalsDacogenEisaiNeurologicalNorth AmericaOncologyperampanelPharmaceuticalRegulation

FDA wants more info on Menveo; advisory negative on Dacogen

13-02-2012

Swiss drug major Novartis (NOVN: VX) said this morning that it has received a Complete Response letter…

Astex PharmaceuticalsDacogenEisaiMenveoNorth AmericaNovartisOncologyPharmaceuticalRegulationVaccines

Astex to return epigenetics project to GSK

17-01-2012

Astex Pharmaceuticals (Nasdaq: ASTX) says that the multi-year collaboration to discover cancer therapeutics…

Astex PharmaceuticalsGlaxoSmithKlineLicensingOncologyPharmaceuticalSuperGen

Astex Thera to merge into SuperGen in cash and stock deal

08-04-2011

USA-based cancer drug developer SuperGen (Nasdaq: SUPG) and privately-held UK biotech firm Astex Therapeutics…

Astex PharmaceuticalsAstex TherapeuticsBiotechnologyMergers & AcquisitionsOncologyPharmaceuticalSuperGen

COMPANY SPOTLIGHT

Menarini

Back to top